Clinical Trials Browser

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Pancreatic Cancer Metastatic

Carcinoma, Hepatocellular

Locally Advanced Pancreatic Cancer

Biliary Tract Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Pancreatic Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Colorectal Neoplasms

Borderline Resectable Pancreatic Adenocarcinoma

BRAF V600 Colorectal Cancer

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Biliary Cancer Metastatic

Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Locally Advanced Rectal Cancer

Colorectal Cancer Metastatic

Colonic Neoplasms

Colorectal Neoplasms

Locally Recurrent Rectal Cancer

Rectal Neoplasms

Clinical Trials

SCOTI

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

PANCREAS

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

PASS-01

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

TRIPP-FFX

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

ERASE-CRC

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

CANTOR

PANC

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Pancreas

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

CEIL

VICTORIA

Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

OPTICAL-2

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

HERBIC

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

ELEVATE CRC

Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma

ShorTrip

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

NAUTICALCRC

Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer

Short-course Radiotherapy or Long-course Chemoradiation Followed by MFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer